$1.56 Billion is the total value of Sofinnova Investments, Inc.'s 53 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
OBSV | Exit | ObsEva SA | $0 | – | -4,749,623 | -100.0% | -0.04% | – |
CTIC | Exit | CTI Biopharma Corpcall | $0 | – | -410,000 | -100.0% | -0.15% | – |
AGEN | Exit | Agenus Inccall | $0 | – | -1,267,000 | -100.0% | -0.18% | – |
CYTK | Exit | Cytokinetics Inccall | $0 | – | -100,000 | -100.0% | -0.27% | – |
FULC | Exit | Fulcrum Therapeutics Inc | $0 | – | -631,411 | -100.0% | -0.27% | – |
GERN | Exit | Geron Corpcall | $0 | – | -2,369,100 | -100.0% | -0.34% | – |
RCUS | Exit | Arcus Biosciences Inc | $0 | – | -314,811 | -100.0% | -0.39% | – |
ALGN | Exit | Align Technology Inc | $0 | – | -83,100 | -100.0% | -1.04% | – |
ALNY | Exit | Alnylam Pharmaceuticals Inccall | $0 | – | -100,000 | -100.0% | -1.41% | – |
UTHR | Exit | United Therapeutics Corp | $0 | – | -89,207 | -100.0% | -1.47% | – |
AZN | Exit | AstraZeneca PLCsponsored adr | $0 | – | -613,673 | -100.0% | -2.47% | – |
VRTX | Exit | Vertex Pharmaceuticals Inc | $0 | – | -156,989 | -100.0% | -2.69% | – |
Exit | Cincor Pharma Inc | $0 | – | -6,073,949 | -100.0% | -4.43% | – | |
SNY | Exit | Sanofi SAsponsored adr | $0 | – | -1,965,475 | -100.0% | -5.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Natera, Inc. | 23 | Q3 2023 | 20.5% |
Ascendis Pharma A/S | 23 | Q3 2023 | 27.9% |
NuCana plc | 23 | Q3 2023 | 15.2% |
Synlogic Inc. (fmrly Mirna) | 22 | Q2 2023 | 0.9% |
Y-mAbs Therapeutics, Inc. | 21 | Q3 2023 | 6.5% |
ObsEva SA | 20 | Q4 2022 | 11.0% |
Nucana PLC | 19 | Q3 2023 | 9.7% |
SYNDAX PHARMACEUTICALS INC | 19 | Q3 2023 | 2.2% |
PDS Biotechnology Corporation | 19 | Q3 2023 | 0.1% |
Karuna Therapeutics, Inc. | 18 | Q3 2023 | 27.1% |
View Sofinnova Investments, Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
OTONOMY, INC.Sold out | February 14, 2022 | 0 | 0.0% |
View Sofinnova Investments, Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-11 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
SC 13G/A | 2022-02-14 |
View Sofinnova Investments, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.